Cardiovascular Systems Stock
Price
Target price
-
-
-
-
-
-
WKN: A0RF8V / Symbol: CSII / Name: Cardiovascular / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Cardiovascular Systems in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cardiovascular Systems vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cardiovascular Systems | - | - | - | - | - | - | - |
| SI-BONE Inc | 0.000% | -3.226% | 14.286% | -26.380% | -28.994% | - | - |
| Lantheus Holdings Inc | 2.200% | 1.407% | 19.806% | 26.536% | 51.224% | 4.418% | - |
| Cryolife Inc. | 0.570% | -10.256% | -42.434% | -29.719% | -55.186% | 25.899% | -25.847% |
News
BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials
BioAge Labs (NASDAQ:BIOA) used its R&D Day event to provide an update on its lead program, BGE-102, an oral, brain-penetrant inhibitor of the NLRP3 inflammasome that the company is developing
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results
Johnson & Johnson’s (NYSE: JNJ) price action entered consolidation in early March. While it may continue moving sideways or even pull back further, those moves are unlikely, given a convergence of